Saturday 17 October 2026
Export CCEL’s income statement to Excel — free account
Cryo-Cell International Inc.
CCEL Healthcare Medical Care Facilities
Cryo-Cell International Inc.’s revenue for fiscal 2025 (year ended November 2025) was $31.6 million, down 1.31% from fiscal 2024. In the quarter to August 2026, revenue was flat, EPS grew 77.8%, free cash flow fell 58.4% and total debt fell 29.5%, each against the same quarter a year earlier.
4.42
0.77
+21.10%
Follow CCEL
| Aug '26 | May '26 | Feb '26 | Nov '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 6 |
+8 more TTM periods Free account |
| 12.46% | 14.80% | 16.12% | 15.27% | ||
| (3.10%) | (3.94%) | (4.26%) | (3.84%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(10.58%) | (15.37%) | (18.79%) | (18.69%) | |
Average Days of Receivables |
80.14 | 81.03 | 79.53 | 79.16 | |
Free Cash Flow per Share |
0.58 | 0.76 | 0.63 | 0.66 | |
Free Cash Flow |
4.65 | 6.11 | 5.06 | 5.36 | |
Capital Expenditures |
(0.27) | (0.21) | (0.12) | (0.12) | |
| Other line items | |||||
Cash ROIC |
(112.76%) | (93.80%) | (87.58%) | (110.81%) | |
Accounts Receivable Turnover |
4.55 | 4.50 | 4.46 | 4.46 | |
Accounts Payable Turnover |
2.65 | 2.70 | 2.33 | 3.10 | |
Inventory Turnover |
11.24 | 13.92 | 12.96 | 13.83 | |
Average Days of Payables |
132.27 | 151.29 | 170.97 | 142.05 | |
Days of Inventory on Hand |
29.15 | 16.48 | 18.49 | 20.23 | |
Tax Rate |
0.02 | (0.03) | (0.05) | 0.04 | |
Research and Development Expense of Revenue |
0.98% | 1.00% | 1.10% | 1.19% | |
Selling, General and Administrative Expense of Revenue |
60.58% | 60.89% | 59.44% | 57.72% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.10 | (0.05) | 0.09 | 0.23 | |
Operating CF/Net income |
(2.53) | (2.56) | (1.94) | (2.26) | |
Depreciation/Fixed assets |
0.07 | 0.07 | 0.07 | 0.07 | |
Capex/Depreciation |
(0.20) | (0.15) | (0.09) | (0.08) | |
Revenue per Share |
3.86 | 3.86 | 3.88 | 3.91 | |
Operating CF per Share |
0.61 | 0.78 | 0.64 | 0.68 | |
Capex per Share |
(0.03) | (0.03) | (0.01) | (0.01) | |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 15 Oct 2026